Article Text

PDF
Journal club summaries
What's hot that the other lot got
  1. Candy Lee
  1. Correspondence to Dr Candy Lee, ST7 Specialty Trainee in Respiratory Medicine and General Internal Medicine, Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Sketty Lane, Swansea, UK, SA2 8QA; clee128{at}doctors.org.uk

Statistics from Altmetric.com

Lobectomy associated with better outcomes in elderly patients with early lung cancer

Survival outcomes of three treatments used for early stage non-small cell lung cancer (NSCLC) was examined in this large, retrospective, population-based study (JAMA Surg 2014; doi: 10.1001/jama surg.2014.556). The authors assessed data on 9093 patients who received definitive treatment with lobectomy, sublobar resection or stereotactic ablative radiotherapy (SABR) between 2003 and 2009. Median age of the patients was 75 years. 79.3% of patients underwent lobectomy, 16.5% had sublobar resections and 4.2% received SABR. After using propensity score matching analysis and proportional hazards regression, lobectomy was found to be associated with better overall survival and lung-specific survival when compared to sublobar resection despite the higher associated surgical risk. SABR was found to have comparable long-term survival outcomes with lobectomy. As such, the authors conclude that SABR may be a good alternative to surgery for patients with very advanced age and multiple co-morbidities.

Long-term erythromycin and respiratory microbiota in bronchiectasis

In this study (Lancet Respir Med 2014; doi: 10.1016/S2213-2600(14)70213–9), gene sequencing of paired sputum samples, taken at baseline and at week 48, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.